Hertab 250mg

Hertab is a prescription medication used to treat certain types of breast cancer, including:

• Advanced breast cancer (metastatic breast cancer) that has spread to other parts of the body
• Breast cancer that has not responded to other treatments

Composition:

Hertab is a tablet containing 250mg of lapatinib.

Mechanism of Action:

Lapatinib works by:

• Blocking the activity of two proteins called HER2 and EGFR, which are involved in the growth and spread of cancer cells
• Reducing the ability of cancer cells to grow and divide

Uses:

Hertab is used to treat:

• Advanced breast cancer (metastatic breast cancer) that has spread to other parts of the body
• Breast cancer that has not responded to other treatments

Dosage:

The recommended dosage of Hertab is:

• 250mg taken orally twice daily with food
• Continue treatment until the disease progresses or unacceptable toxicity occurs

Side Effects:

Common side effects of Hertab include:

• Diarrhea
• Nausea and vomiting
• Fatigue
• Headache
• Hair loss
• Skin rash
• Increased risk of infection
• Increased risk of bleeding

Recommendation:

Hertab is recommended for patients with advanced breast cancer who have not responded to other treatments. Patients should also be advised to monitor their liver function and kidney function regularly during treatment.

Important Note:

Patients should not take Hertab if they have a history of severe allergic reactions, liver problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Hertab.

Some common brands of lapatinib include:

• Tykerb (GlaxoSmithKline)
• Lapatinib (GlaxoSmithKline)

Please note that Hertab is not available in all markets and may be approved for different indications and dosages in different regions.